Covaxin EUL In WHO: When will the emergency use of Covaxin be approved by WHO? know here

Covaxin EUL In WHO: Bharat Biotech’s Corona Vaccine has not yet received Emergency Use Listing (EUL) approval from WHO. There has been a meeting of the WHO’s Technical Advisory Group several times regarding this and every time new data was asked from the company – vaccine efficacy, immunogenicity and risk assessment data, which has been given. In the meeting held on October 26, Bharat Biotech, which manufactures the covaccine, has been asked for the Final Risk Benefit for Global Use, on which a decision can be taken after November 3.

World Health Organization (WHO) Chief Scientist Dr. Soumya Swaminathan had informed by tweeting on October 27 that the assessment data of the Final Risk Benefit for Global Use has been sought from Bharat Biotech, the company that makes the vaccine, which was discussed in the meeting on 3 November. Will consider.

At the same time, the WHO was questioned on the emergency use listing of the vaccine on October 20, in response to which Dr. Mike Ryan, executive director of the WHO Health Emergency Program, said, “If any vaccine is given a WHO emergency use listing, then everything should be checked. Take it, whether it is the efficacy of the vaccine or the process of making it, because the world will use it and this whole process happens.”

Dr. Mike Ryan said, “WHO is very clear. We want all countries to recognize vaccines that have been given the EUL through the WHO advisory process. It’s really important that we get all the necessary information, not only on the vaccine itself, but on manufacturing it.” Process and collect on all of them, as we are recommending to the world that this vaccine is safe and effective and is produced using the highest quality and standards.”

Let us tell you that Covaxin is waiting for emergency approval of WHO for a long time. For this Bharat Biotech had filed an expression of interest in the month of April itself. After getting the approval of the EUL, the restrictions for international travel for those who have got the vaccine in India will also be softened. Along with this, the way for export of covaccine will also be opened.

Before the meeting of 26 October, the Union Health Ministry also hoped that India’s indigenous corona vaccine Covaccine could be approved in this meeting. The Union Health Minister himself had mentioned this. He said, “WHO has its own procedure. First the technical committee looks after, then the second committee looks. The technical committee has given a positive sign, the second sub-committee is meeting today. Today is the meeting of WHO and it is expected that Covaccine will get EUL soon.”

The number of times the data sought by the company that makes the vaccine so far has been given to the WHO from time to time. In a special conversation with ABP News, Dr. Krishna Ella of Bharat Biotech had told that the company has given every data that is being sought to WHO.

‘Right on the detail analysis of the vaccine’

At the same time, according to the experts, WHO has its own process. According to Dr. Sanjay Rai of the Indian Public Health Association, a doctor of community medicine who has conducted clinical trials of the vaccine at AIIMS in Delhi, the more detailed analysis it is before the approval of the vaccine, the better it will be and the right vaccine will reach the people. He said that this is a matter of science, the role of the government should not be there, science will do this work only while doing its process.

So far, WHO has given EUL to six vaccines. These include vaccines from Pfizer-BioNtech, AstraZeneca-SK Bio-Serum Institute of India, AstraZeneca EU, Janssen, Moderna and Sinopharm. It is expected that in the meeting to be held in November, Bharat Biotech’s Covaccine will find a place in the emergency use listing of WHO. Clinical trial of this vaccine took place in India and emergency use has been approved on 3 January this year.


Source link

- Advertisement -